BioSmart Co

BioSmart Co Revenue

The The revenue of BioSmart Co (038460.KQ) as of Nov 19, 2026 is 482.78 B KRW. In the previous year, The revenue was 484.31 B KRW — a change of -0.32% (lower).

Revenue

482.78 BKRW

YoY

-0.32%

Last updated:

In 2025, BioSmart Co's sales reached 482.78 B KRW, a -0.32% difference from the 484.31 B KRW sales recorded in the previous year.

Over the last 19 years BioSmart Co grew revenue by 18.5% annually, reaching 482.78 B KRW.

The BioSmart Co Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2018
117.73 B KRW
Jan 1, 2019
158.97 B KRW
Jan 1, 2020
166.43 B KRW
Jan 1, 2021
189.18 B KRW
Jan 1, 2022
391.82 B KRW
Jan 1, 2023
456.16 B KRW
Jan 1, 2024
484.31 B KRW
Jan 1, 2025
482.78 B KRW
The BioSmart Co Revenue history
YEARRevenueYoY
482.78 BKRW-0.32%
484.31 BKRW+6.17%
456.16 BKRW+16.42%
391.82 BKRW+107.11%
189.18 BKRW+13.67%
166.43 BKRW+4.69%
158.97 BKRW+35.02%
117.73 BKRW+46.37%
80.43 BKRW+27.69%
62.99 BKRW+16.25%
54.19 BKRW+30.56%
41.50 BKRW+2.88%
40.34 BKRW-4.84%
42.40 BKRW+25.79%
33.70 BKRW+5.90%
31.82 BKRW+4.25%
30.53 BKRW+32.70%
23.01 BKRW-18.63%
28.27 BKRW+46.74%
19.27 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioSmart Co Revenue

BioSmart Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
117.73 B KRW
6.73 B KRW
5.14 B KRW
Jan 1, 2019
158.97 B KRW
24.54 B KRW
22.15 B KRW
Jan 1, 2020
166.43 B KRW
-1.49 B KRW
-8.74 B KRW
Jan 1, 2021
189.18 B KRW
4.99 B KRW
1.39 B KRW
Jan 1, 2022
391.82 B KRW
9.69 B KRW
721.31 M KRW
Jan 1, 2023
456.16 B KRW
22.44 B KRW
17.91 B KRW
Jan 1, 2024
484.31 B KRW
15.89 B KRW
127.17 M KRW
Jan 1, 2025
482.78 B KRW
22.72 B KRW
9.01 B KRW

BioSmart Co Margins

BioSmart Co stock margins

The BioSmart Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioSmart Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioSmart Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
36.43 %
5.72 %
4.36 %
Jan 1, 2019
35.37 %
15.44 %
13.93 %
Jan 1, 2020
35.39 %
-0.89 %
-5.25 %
Jan 1, 2021
36.17 %
2.64 %
0.74 %
Jan 1, 2022
19.58 %
2.47 %
0.18 %
Jan 1, 2023
17.32 %
4.92 %
3.93 %
Jan 1, 2024
16.99 %
3.28 %
0.03 %
Jan 1, 2025
17.66 %
4.71 %
1.87 %

BioSmart Co Stock analysis

What does BioSmart Co do? BioSmart Co is one of the most popular companies on Eulerpool.

Revenue Details

Understanding BioSmart Co's Sales Figures

The sales figures of BioSmart Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing BioSmart Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize BioSmart Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in BioSmart Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about BioSmart Co stock

The revenue of BioSmart Co is 482.78 B KRW in 2025.

The revenue of BioSmart Co changed from 484.31 B KRW to 482.78 B KRW, representing a -0.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The revenue BioSmart Co since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's BioSmart Co historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — BioSmart Co

All Key Metrics — BioSmart Co